Concept:
Atherosclerosis involves the formation of plaques and blood clots in arteries, reducing blood flow.
• Clots can block arteries, leading to heart attack or stroke.
• Recombinant DNA technology is used to produce therapeutic proteins.
Step 1: Understand treatment goal.
Treatment aims to dissolve blood clots and restore blood flow.
Step 2: Identify correct protein.
Tissue plasminogen activator (tPA) converts plasminogen into plasmin, which dissolves fibrin clots.
Step 3: Analyze options.
• (A) Platelet derived growth factor: Involved in cell growth
• (B) Interleukin-1 receptor: Immune response mediator
• (C) Tissue plasminogen activator: Dissolves clots (correct)
• (D) Macrophage activating factor: Immune function
Step 4: Conclusion.
Thus, atherosclerosis is treated using recombinant tPA.
Final Answer: Option (C)